A new, independently conducted clinical study in Experimental and Clinical Psychopharmacology offers rare, high-quality evidence on how oral nicotine pouches perform for people who already use smokeless tobacco (SLT) and
At InterTabac, GINN’s Phil Hudson sat down with Hannu Karvonen, representing Denssi nicotine pouches, a Finnish brand making waves in Europe and beyond. In their conversation, Karvonen shared how Denssi
At InterTabac 2025, GINN’s Phil Hudson sat down with Shivam Bihani, co-founder of MYNT Nicotine Pouches, to discuss the company’s origins, market growth, and vision for the future of oral
Policies meant to restrict access to nicotine pouches are turning out to be counterproductive, especially for workers, whose access to tobacco alternatives is already constrained by time, location, and economic
At the New Approaches Summit 2025, the conversation around oral pouches moved beyond nicotine. What began as a harm reduction innovation has now evolved into a platform with potential far
On the evening of 18 September 2025, the PouchXchange event at InterTabac – InterSupply in Dortmund brought together leading figures in the oral nicotine products sector. Organized as an industry
Bangladesh is at a crossroads in its fight against tobacco. Despite decades of tobacco control policies, the country still faces some of the highest smoking and smokeless tobacco use rates
In September 2025, France confirmed plans to ban the sale of nicotine pouches starting in 2026, a move hailed by anti-tobacco groups but criticized by harm reduction advocates as a
The U.S. Food and Drug Administration (FDA) is accelerating its review of nicotine pouches, responding to mounting pressure from the White House to clarify the regulatory status of one of
GINN is delighted to welcome Asian Trade Media Group as both our newest member and media partner, an important step that strengthens our mission to build a global community grounded
The rapid growth of the oral nicotine pouch category has been one of the most significant shifts in global tobacco harm reduction over the past decade. From Sweden to the
The U.S. Food and Drug Administration (FDA) has announced strengthened requirements for child-resistant packaging (CRP) on nicotine products, underscoring the critical importance of safeguarding children while balancing access for adult
